重建性手术治疗种植体周围炎相关骨缺损的疗效:系统综述与Meta分析
本系统综述纳入16项报告重建性手术治疗种植体周围炎相关骨缺损12个月结局的研究,其中3项对照研究(116枚种植体)评估了重建技术相对于对照的潜在获益。Meta分析显示试验组边缘骨水平改善更大(WMD=1.7 mm)、缺损填充更优(WMD=57%),但临床指标(探诊深度和探诊出血减少)无差异;整体结局显示边缘骨水平、临床附着水平改善及探诊深度和探诊出血减少。
要点
- 重建手术在12个月时可改善边缘骨水平和缺损填充,但临床指标与对照无差异。
- 整体结局显示边缘骨水平、临床附着水平改善及探诊深度和出血减少。
- 证据受限于对照研究少、研究间异质性高及结局指标选择。
核心结论
- 重建性手术治疗种植体周围炎相关骨缺损的现有证据有限,受对照研究数量少、常用术式缺乏对照研究、研究间异质性及结局指标选择限制。
- 12个月预测结局变异度高,试验组边缘骨水平增益更大但移植物材料可能与新骨难以区分,美学和患者报告获益尚待证实。
研究设计与样本
- 系统综述与Meta分析,通过电子检索识别报告种植体周围炎相关骨缺损重建手术12个月结局的研究。
- 共16项研究报告重建措施术后12个月结局,其中3项对照研究(共116枚种植体)评估重建技术相对于对照的潜在获益。
- Meta分析分两组:对照研究评估重建手术相对对照的潜在获益;整体结局比较基线值与12个月结局。
- 结果以加权均数差(WMD)或风险比(RR)表示,异质性以I2和预测区间描述。
主要发现
- 对照研究Meta分析显示试验组边缘骨水平改善更大(WMD=1.7 mm)、缺损填充更优(WMD=57%),但探诊深度减少和探诊出血减少无差异。
- 整体结局显示边缘骨水平改善(WMD=2.0 mm)、临床附着水平改善(WMD=1.8 mm)、退缩(WMD=0.7 mm)、探诊深度减少(WMD=2.8 mm)及探诊出血减少(种植体RR=0.4/位点RR=0.2)。
- 未考虑临床附着和软组织水平变化,无研究涉及患者报告结局指标。
临床怎么用
- 重建手术可考虑用于种植体周围炎相关骨缺损以改善边缘骨水平和缺损填充,但临床指标获益与对照无差异。
- 决策时需注意证据异质性高、12个月预测结局变异大,美学和患者报告获益尚未证实。
局限性
- 对照研究数量少(仅3项,116枚种植体)。
- 常用术式缺乏对照研究。
- 研究间异质性高。
- 结局指标选择受限,未评估临床附着和软组织水平变化。
- 无研究涉及患者报告结局指标,移植物材料与新骨难以区分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The present systematic review aimed at evaluating the efficacy of reconstructive surgical therapy at peri-implantitis-related bone defects. METHODS: Studies reporting on outcomes of reconstructive surgery at peri-implantitis-related bone defects at 12 months were identified through an electronic search. Following data extraction, two different sets of meta-analyses were performed. Primarily, controlled studies were used to evaluate the potential benefit of reconstructive surgical therapy over controls. Secondly, overall outcome of reconstructive surgical therapy was assessed by comparing baseline values with outcomes at 12 months. Results were expressed as weighted mean differences (WMD) or risk ratios (RR). Heterogeneity was described by I2 and prediction intervals. RESULTS: The potential benefit of reconstructive techniques over control procedures was evaluated in three studies, representing a total of 116 implants. Altogether, 16 studies reported on the outcome of reconstructive measures at 12 months after surgery. The meta-analyses identified a larger improvement in marginal bone levels (MBL, WMD = 1.7 mm) and in defect fill (WMD = 57%) for test procedures, but found no differences for clinical measures (reduction of probing depth (PD) and bleeding on probing (BOP). Changes of clinical attachment and soft tissue levels were not considered. In terms of overall outcome, therapy resulted in improved MBL (WMD = 2.0 mm) and CAL (WMD = 1.8 mm), in recession (WMD = 0.7 mm), in reduced PD (WMD = 2.8 mm) and in reduced BOP (Implants: RR = 0.4/Sites: RR = 0.2). None of the included studies addressed patient-reported outcome measures. CONCLUSIONS: The available evidence on reconstructive therapy at peri-implantitis-related defects is limited by (a) the low number of controlled studies, (b) the lack of controlled studies for commonly used procedures, (c) the heterogeneity between studies and (d) the choice of outcome measures. A high variability for predicted outcomes at 12 months was noted. The interpretation of the demonstrated larger MBL gain for test procedures is difficult as graft material may not be distinguishable from newly formed bone. Potential aesthetic and patient-reported advantages remain to be demonstrated.
引用
- Tomasi C, Regidor E, Ortiz-Vigón A, et al. Efficacy of reconstructive surgical therapy at peri-implantitis-related bone defects. A systematic review and meta-analysis. J Clin Periodontol. 2019. PMID: 30667523. doi:10.1111/jcpe.13070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。